Anders Andersen

1.7k total citations
75 papers, 1.4k citations indexed

About

Anders Andersen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anders Andersen has authored 75 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Cardiology and Cardiovascular Medicine and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anders Andersen's work include Acute Lymphoblastic Leukemia research (10 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Anders Andersen is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Anders Andersen collaborates with scholars based in Norway, United States and Denmark. Anders Andersen's co-authors include Lars Slørdal, David J. Warren, Harald Olsen, David J. Warren, Kirsten Sundby Hall, J. Ladefoged, Nils Tore Vethe, Stein Bergan, Knut Rasmussen and Lars Mørkrid and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Joint Surgery and British Journal of Cancer.

In The Last Decade

Anders Andersen

73 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Andersen Norway 20 253 238 223 207 196 75 1.4k
Roger P. Smith United States 21 269 1.1× 434 1.8× 299 1.3× 160 0.8× 244 1.2× 69 1.8k
Jake J. Thiessen Canada 23 234 0.9× 337 1.4× 177 0.8× 60 0.3× 255 1.3× 69 1.6k
Massimo Sabbatini Italy 30 361 1.4× 91 0.4× 249 1.1× 133 0.6× 281 1.4× 101 2.7k
B Magnani United States 19 251 1.0× 76 0.3× 197 0.9× 137 0.7× 113 0.6× 69 1.3k
Kenji Matsumoto Japan 22 612 2.4× 173 0.7× 306 1.4× 78 0.4× 183 0.9× 153 2.3k
Giorgio Attinà Italy 21 257 1.0× 288 1.2× 173 0.8× 120 0.6× 234 1.2× 114 1.3k
Robert J. Noveck United States 27 229 0.9× 131 0.6× 294 1.3× 103 0.5× 161 0.8× 70 2.0k
Catherine Y. Lau United States 24 413 1.6× 250 1.1× 186 0.8× 113 0.5× 103 0.5× 84 2.1k
Qin Xu China 21 317 1.3× 335 1.4× 235 1.1× 127 0.6× 147 0.8× 98 1.5k
Niels Nygaard Rossing Denmark 27 315 1.2× 399 1.7× 482 2.2× 119 0.6× 495 2.5× 99 2.5k

Countries citing papers authored by Anders Andersen

Since Specialization
Citations

This map shows the geographic impact of Anders Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Andersen more than expected).

Fields of papers citing papers by Anders Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Andersen. The network helps show where Anders Andersen may publish in the future.

Co-authorship network of co-authors of Anders Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Andersen. A scholar is included among the top collaborators of Anders Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Andersen. Anders Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munkhaugen, John, Stein Bergan, Kari Peersen, et al.. (2024). The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study. SHILAP Revista de lepidopterología. 55. 31–38. 2 indexed citations
2.
Vethe, Nils Tore, et al.. (2023). Clinical performance of volumetric finger‐prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipients. British Journal of Clinical Pharmacology. 89(12). 3690–3701. 12 indexed citations
3.
Bergan, Stein, et al.. (2021). In vitro assessments predict that CYP3A4 contributes to a greater extent than CYP3A5 to prednisolone clearance. Basic & Clinical Pharmacology & Toxicology. 129(6). 427–436. 6 indexed citations
4.
Andersen, Anders, Stein Bergan, Tobias Gedde‐Dahl, Jochen Buechner, & Nils Tore Vethe. (2021). Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipients. Journal of Pharmaceutical and Biomedical Analysis. 203. 114216–114216. 8 indexed citations
5.
Andersen, Anders, et al.. (2019). Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei. Clinical & Experimental Metastasis. 36(6). 511–518. 6 indexed citations
6.
Fagermoen, Even, Dag Sulheim, Anette Winger, et al.. (2015). Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial. BMC Pediatrics. 15(1). 117–117. 11 indexed citations
7.
Vethe, Nils Tore, Ulf E. Kongsgaard, Anders Andersen, et al.. (2013). Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring. Scandinavian Journal of Clinical and Laboratory Investigation. 73(2). 117–124. 12 indexed citations
8.
Andersen, Anders, et al.. (2011). High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients. British Journal of Clinical Pharmacology. 73(1). 106–114. 106 indexed citations
9.
Novovic, Srdan, Anders Andersen, Annette Kjær Ersbøll, et al.. (2011). Mannan-Binding Lectin and Mannan-Binding Lectin-Associated Serine Protease 2 in Acute Pancreatitis. Pancreas. 40(7). 1097–1102. 2 indexed citations
10.
Edvardsen, Hege, Paal Brunsvig, Hiroko Kato Solvang, et al.. (2010). SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance. The Pharmacogenomics Journal. 10(6). 513–523. 18 indexed citations
11.
Kongsgaard, Ulf E., et al.. (2008). Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES. Acta Anaesthesiologica Scandinavica. 52(3). 406–412. 7 indexed citations
12.
Gotlieb, Walter H., Ilan Bruchim, Gilad Ben‐Baruch, et al.. (2006). Doxorubicin levels in the serum and ascites of patients with ovarian cancer. European Journal of Surgical Oncology. 33(2). 213–215. 10 indexed citations
13.
Andersen, Anders, David J. Warren, Paal Brunsvig, et al.. (2006). High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection. PubMed. 6(1). 2–2. 59 indexed citations
14.
Seidel, H., Anders Andersen, Jan Terje Kvaløy, et al.. (2000). Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables. Leukemia Research. 24(3). 193–199. 29 indexed citations
15.
Agertoft, Lone, et al.. (1999). Systemic availability and pharmacokinetics of nebulised budesonide in preschool children. Archives of Disease in Childhood. 80(3). 241–247. 65 indexed citations
16.
Ekstrøm, Per Olaf, Anders Andersen, David J. Warren, Karl Erik Giercksky, & Lars Slørdal. (1996). Determination of extracellular methotrexate tissue levels by microdialysis in a rat model. Cancer Chemotherapy and Pharmacology. 37(5). 394–400. 15 indexed citations
17.
Andersen, Anders, et al.. (1995). A High-Pressure Liquid Chromatographic Method for Measuring Mitotane. Therapeutic Drug Monitoring. 17(5). 526–531. 10 indexed citations
18.
Andersen, Anders, et al.. (1994). Quantition of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration. Cancer Chemotherapy and Pharmacology. 34(3). 197–202. 10 indexed citations
19.
Loennechen, Thrina, Inge W. Nilsen, Ugo Moens, Anders Andersen, & Jarle Aarbakke. (1992). Is there an association between an increase in c-myc RNA steady state levels and c-myc methylation in HL-60 cells treated with 3-deaza-(±)-aristeromycin, an indirect inhibitor of methylation?. Biochemical Pharmacology. 44(7). 1283–1289. 5 indexed citations
20.
Loennechen, Thrina, et al.. (1990). High-Performance Liquid Chromatographic Determination of Levomepromazine (Methotrimeprazine) and Its Main Metabolites in Serum and Urine. Therapeutic Drug Monitoring. 12(6). 574–581. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026